Scientists are racing to get their functions in for NIH’s
newest scheme for utilizing the $10.four billion it obtained within the
stimulus invoice—jumbo-sized Grand Alternatives, or GO, grants.
It should spend $200 million on 2-year awards funded for $1
million or extra—not less than 35% bigger than R01 grants, the
mainstay of the NIH system.
Not like NIH’s different huge stimulus competitors, the Problem
Grants, which may be as much as $1 million, the GO tasks will
require not less than that a lot cash. NIH needs to fund “excessive
impression” short-term tasks, which might imply answering a
analysis query or creating infrastructure. That may entail
validating illness biomarkers or utilizing data know-how
to share radiology photographs throughout hospitals.
Many NIH institutes have listed particular tasks they’re
Johns Hopkins College molecular pathologist Anirban Maitra
says the GO grants are “like a giant sister” to the Problem
Grants; he means that solely “the massive guys” will attempt for them.
Not like the Problem Grants, which might draw 10,000
functions, this competitors will not generate an avalanche of
proposals that should be peer-reviewed. That is as a result of grant
seekers first should ship NIH a letter of intent (by 27
April), which NIH workers will use to pare down the potential
proposals. The company introduced the GO
competition on 23 March however for some cause solely obtained round
to issuing a press launch today.
Source : http://www.sciencemag.org/news/2009/04/nih-unleashes-mondo-mega-grants-devour-disease